Stifel Financial Corp Acquires 16,458 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stifel Financial Corp grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 396,964 shares of the medical equipment provider's stock after purchasing an additional 16,458 shares during the period. Stifel Financial Corp owned approximately 0.11% of Intuitive Surgical worth $195,017,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of ISRG. Ridgewood Investments LLC acquired a new position in Intuitive Surgical during the second quarter worth about $26,000. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after acquiring an additional 35 shares during the period. LGT Financial Advisors LLC grew its holdings in Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 54 shares during the period. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the third quarter worth about $33,000. Finally, Mark Sheptoff Financial Planning LLC acquired a new position in Intuitive Surgical during the second quarter worth about $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded up $2.76 during trading on Friday, hitting $550.41. 1,026,203 shares of the stock traded hands, compared to its average volume of 1,445,625. The stock has a market cap of $196.04 billion, a P/E ratio of 88.49, a PEG ratio of 5.33 and a beta of 1.38. Intuitive Surgical, Inc. has a twelve month low of $307.72 and a twelve month high of $556.23. The company has a fifty day moving average price of $514.78 and a two-hundred day moving average price of $472.60.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity

In related news, EVP Brian Edward Miller sold 2,553 shares of the firm's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares of the company's stock, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amy L. Ladd sold 450 shares of the firm's stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares in the company, valued at $402,519.88. The trade was a 35.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 51,023 shares of company stock worth $26,384,247 in the last three months. 0.90% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Truist Financial increased their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Morgan Stanley upgraded Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their price target for the company from $522.00 to $650.00 in a research report on Monday. Piper Sandler reiterated an "overweight" rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Robert W. Baird increased their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $541.33.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.